Literature DB >> 15222024

Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Hong-Ling Li1, Bing-Zhong Sun, Fu-Cheng Ma.   

Abstract

AIM: To assess the expression of cyclooxygenase-2 (COX-2), nitric oxide synthase (iNOS), p53 and Ki-67 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and clarify the relationship between COX-2 expression and iNOS or p53 expression in these patients.
METHODS: The expressions of COX-2, iNOS, p53 and Ki-67 were detected in 32 gastric MALT lymphoma specimens and 10 adjacent mucosal specimens by immunohistochemical Envision method.
RESULTS: COX-2 and iNOS expressions were significantly higher in gastric MALT lymphoma tissues than those in adjacent normal tissues. The expression of COX-2 was observed in 22 of 32 cases of MALT lymphoma tissues (68.8%). A positive cytoplasmic immunoreactivity for iNOS was detected in 17 of 31 cases (53.1%). COX-2 expression in gastric MALT lymphoma tissues was positively correlated with iNOS expression (r=0.448, P=0.010) and cell proliferative activity analyzed by Ki-67 labeling index (r=0.410, P=0.020). The expression of COX-2 protein did not correlate with age, sex, stage of disease, lymph node metastasis or differentiation. The accumulation of p53 nuclear phosphoprotein was detected in 19(59.4%) of tumors. p53 protein was expressed in 11 of 23 assessed LG tumors and in 8 of 9 assessed HG tumors. The difference of p53 positivity was found statistically significant between LG and HG cases (P=0.0302). The p53 accumulation correlated with advanced clinical stage (stage III+IV vs stage I+II, P=0.017). There was a significant positive correlation between COX-2 expression and p53 accumulation status (r=0.403, P=0.022). The mean PI of Ki-67 in each grade group were 36.0+/-7.73% in HG and 27.4+/-9.21% in LG. High-proliferation rate correlated with HG tumors (r=0.419, P=0.017). The correlation coefficient showed a significant positive correlation between PI and COX-2 expression in MALT lymphoma patients (r=0.410, P=0.020).
CONCLUSION: COX-2 expresses in the majority of gastric MALT lymphoma tissues and correlates with cellular proliferation and iNOS expression. COX-2 overexpression is closely associated with p53 accumulation status. iNOS and COX-2 may play a synergistic role in the pathogenesis of gastric MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222024      PMCID: PMC4572218          DOI: 10.3748/wjg.v10.i13.1862

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis.

Authors:  Jeong A Han; Jong-Il Kim; Pat P Ongusaha; Daniel H Hwang; Leslie R Ballou; Alka Mahale; Stuart A Aaronson; Sam W Lee
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

2.  The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.

Authors:  Ornella Fantappiè; Emanuela Masini; Iacopo Sardi; Laura Raimondi; Daniele Bani; Michela Solazzo; Alfredo Vannacci; Roberto Mazzanti
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

3.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue.

Authors:  M Kojima; T Morisaki; Y Tsukahara; A Uchiyama; Y Matsunari; R Mibu; M Tanaka
Journal:  J Surg Oncol       Date:  1999-04       Impact factor: 3.454

4.  Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.

Authors:  Hong Zhang; Xiao-Feng Sun
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

5.  Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.

Authors:  Ben S Zweifel; Thomas W Davis; Richard L Ornberg; Jaime L Masferrer
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.

Authors:  O Kobayashi; H Miwa; S Watanabe; M Tsujii; R N Dubois; N Sato
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Gastric MALT-lymphoma, gastrin and cyclooxygenases.

Authors:  P C Konturek; S J Konturek; P Pierzchalski; T Starzyńska; K Marlicz; A Hartwich; M Zuchowicz; Z Darasz; D Papiez; E G Hahn
Journal:  Acta Gastroenterol Belg       Date:  2002 Jan-Mar       Impact factor: 1.316

8.  Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.

Authors:  Yasuyoshi Miyata; Shigehiko Koga; Shigeru Kanda; Masaharu Nishikido; Tomayoshi Hayashi; Hiroshi Kanetake
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

9.  Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines.

Authors:  Qiang Liu; S T F Chan; Ratha Mahendran
Journal:  Carcinogenesis       Date:  2003-04       Impact factor: 4.944

10.  Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Authors:  Carsten Denkert; Klaus-Jürgen Winzer; Berit-Maria Müller; Wilko Weichert; Sören Pest; Martin Köbel; Glen Kristiansen; Angela Reles; Antje Siegert; Hans Guski; Steffen Hauptmann
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

View more
  18 in total

1.  Angiogenesis in nodal B cell lymphomas: a high throughput study.

Authors:  Alexandar Tzankov; Simone Heiss; Stephanie Ebner; William Sterlacci; Georg Schaefer; Florian Augustin; Michael Fiegl; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.

Authors:  Xuesong Han; Tongzhang Zheng; Qing Lan; Yaqun Zhang; Briseis A Kilfoy; Qin Qin; Nathaniel Rothman; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 3.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  Ki-67 proliferative marker in lymph node aspirates of patients with non-Hodgkin's lymphoma.

Authors:  B Mihaljević; R Nedeljkov-Janćić; V Cemerikić-Martinović; D Babić; M Colović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.

Authors:  Soumia Zeggai; Noria Harir; Abdelnacer Tou; Feriel Sellam; Meriem N Mrabent; Rachida Salah
Journal:  J Gastrointest Oncol       Date:  2016-06

6.  Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma.

Authors:  Yingying Cui; Zhenchang Sun; Xin Li; Changsen Leng; Lei Zhang; Xiaorui Fu; Ling Li; Xudong Zhang; Y U Chang; Feifei Nan; Zhaoming Li; Jiaqin Yan; Mingzhi Zhang; Wencai Li; Guannan Wang; Dandan Zhang; Yaozhen Ma
Journal:  Oncol Lett       Date:  2015-11-20       Impact factor: 2.967

Review 7.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

8.  Odontogenic epithelial proliferation is correlated with COX-2 expression in dentigerous cyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Hitoshi Miyashita; Takahiro Taniguchi; Sheng Rong Zhu
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

9.  Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients.

Authors:  Laura Neumann; Mattea Mueller; Verena Moos; Frank Heller; Thomas F Meyer; Christoph Loddenkemper; Christian Bojarski; Michael Fehlings; Thomas Doerner; Kristina Allers; Toni Aebischer; Ralf Ignatius; Thomas Schneider
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

10.  NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.

Authors:  Haifeng Zhu; Deeksha Vishwamitra; Choladda V Curry; Roxsan Manshouri; Lixia Diao; Aarish Khan; Hesham M Amin
Journal:  J Pathol       Date:  2013-03-14       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.